Catalent
CTLT
#1737
Rank
ยฃ8.64 B
Marketcap
ยฃ47.65
Share price
0.00%
Change (1 day)
8.98%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ0.25 Billion

According to Catalent's latest financial reports the company has ยฃ0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30ยฃ0.22 B-50.21%
2022-06-30ยฃ0.44 B-36.73%
2021-06-30ยฃ0.69 B-9.1%
2020-06-30ยฃ0.76 B182.71%
2019-06-30ยฃ0.27 B-12.38%
2018-06-30ยฃ0.31 B31.62%
2017-06-30ยฃ0.23 B126.9%
2016-06-30ยฃ0.10 B7.81%
2015-06-30ยฃ96.44 M121.8%
2014-06-30ยฃ43.48 M-37.86%
2013-06-30ยฃ69.97 M-21.02%
2012-06-30ยฃ88.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Supernus Pharmaceuticals
SUPN
ยฃ0.21 B-16.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.12 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ1.53 B 510.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
ยฃ0.24 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA